Related Experiment Videos
Parenteral iron therapy exacerbates experimental sepsis
Richard A Zager1, Ali C M Johnson, Sherry Y Hanson
1Department of Medicine, University of Washington, and the Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. dzager@fhcrc.org
Kidney International
|May 20, 2004
Summary
Parenteral iron administration worsens experimental sepsis, increasing oxidative stress and tumor necrosis factor-alpha (TNF-alpha) levels. This combination led to a 60% mortality rate in mice, highlighting potential risks in clinical sepsis.
Area of Science:
- Biomedical Science
- Pharmacology
- Toxicology
Background:
- Catalytic iron can worsen systemic inflammation through pro-oxidant effects.
- Parenteral iron administration may exacerbate existing septic conditions.
Purpose of the Study:
- To experimentally investigate if parenteral iron administration exacerbates experimental sepsis.
Main Methods:
- Male CD-1 mice were induced with sepsis using heat-killed Escherichia coli.
- Intravenous iron sucrose was administered concurrently with sepsis induction.
- Plasma tumor necrosis factor-alpha (TNF-alpha) and tissue heme oxygenase-1 (HO-1) levels were measured.
- Morbidity and mortality rates were assessed at 24 hours.
Main Results:
- Both iron and sepsis alone increased oxidative stress markers (HO-1).
- Combined iron and sepsis administration showed additive or synergistic increases in HO-1.
- Iron administration significantly amplified TNF-alpha levels in septic mice.
- The combination of iron and sepsis resulted in approximately 60% mortality.
Conclusions:
- Parenteral iron induces oxidative stress and TNF-alpha release.
- Concurrent iron administration during experimental sepsis profoundly increases these markers and mortality.
- The potential for parenteral iron to worsen clinical sepsis, especially in vulnerable patients, warrants further investigation.